INTRODUCTION
Charcot -Marie -Tooth (CMT) disease is the most common inherited motor and sensory peripheral neuropathy (1, 2) . Patients affected by CMT have motor deficits associated with muscle weakness and pain which occur mostly in the lower limbs. Currently, there is no available treatment except for physiotherapy or invasive surgery. CMT is a genetically and phenotypically heterogeneous disease and has been classified into two principal categories: type 1 and type 2, which are, respectively, associated with myelin defects and axonal abnormalities (3) .
As CMT1 is the most common form of the disease, most transgenic mouse models of CMT generated mimic the CMT1 phenotype (4) . To date, only three transgenic mice have been elaborated from CMT2-associated mutations.
Kif5B
+/2 mice suffer from progressive muscular weakness resulting from defects of axonal transport (5) . Motor neuronspecific expression of the mitofusin2 T105M CMT2A mutation leads to severe hindlimb defects due to muscular weakness and motor axon loss in mice (6) . Moreover, knocking out the Lmna gene encoding nuclear IF Lamin A/C causes a peripheral neuropathy in mice associated with the reduction of axon density, axonal enlargement, and the presence of nonmyelinated axons in the sciatic nerve (7) . Neurofilaments (NFs) are one of the main components of the neuronal cytoskeleton and are composed of three subunits: NF-L, NF-M and NF-H (light, medium and heavy subunit). The light subunit, NF-L, co-assembles with NF-M and NF-H to form the NF network. In the central nervous system, a-internexin also co-assembles with NF proteins. NFs are implicated in various cellular processes, including axonal radial growth and axonal transport. Changes in the stoichiometry or assembly of NF proteins can lead to abnormal NF accumulations in neuronal perikaryon or axon (8) . To date, up to 18 NEFL mutations have been associated with axonal CMT2E (9 -18) . The P22S mutation in NEFL was first discovered in a Slovenian family (19) and causes an earlier symptomatic form of CMT with pathological axonal deformation and swelling (10, 16) . The NEFL P22S mutation is located in the N-terminal head domain of NF-L, a key domain regulating NF assembly through phosphorylation by second-messenger-dependent protein kinases. The P22S mutation abolishes the Thr -Pro Proline-directed protein kinase (PDPK) consensus phosphorylation sequence, therefore perturbing the regulation of NF assembly by phosphorylation (20) . As predicted, in vitro studies confirmed that most mutated NF-L proteins fail to self-assemble or to co-assemble with wild-type NF-L, NF-M and NF-H. The inability of mutant NF-L to form a proper NF network causes aggregation of NFs in SW13Vim 2 cells, neuronal cell lines, cultured rat cortical neurons and DRG neurons (21, 22) . Perez-Olle et al. (22) showed that these aggregations could trap motor proteins and organelles in the cytoplasm, resulting in defects of axonal transport in vitro. Moreover, it has recently been shown that NF-L mutants P8R and Q333P could cause the degeneration of primary cultured motor neurons via NF-L aggregation and defective axonal transport (23) . If correct, these in vitro studies would suggest that the CMT2E disease may undergo irreversible damages after disease onset has taken place.
Here, we report the generation of the first mouse model of the CMT2E disease. Moreover, this animal model is based on the tetracycline-responsive gene system (tet-off system) that allows the suppression of mutant hNF-L P22S expression in mature neurons through administration of doxycycline. The hNF-L
P22S
;tTa mice recapitulated the key features of CMT2E neuropathy with abnormal hindlimb posture at 9 months of age associated with motor deficits, hypertrophy of muscle fibres and loss of muscle innervation. Remarkably, the suppression of mutant hNF-L P22S production after disease onset by doxycycline treatment of transgenic mice reversed the neurological phenotypes.
RESULTS

Generation of hNF-L P22S ;tTa double transgenic mice
We generated double transgenic mice with expression of mutant hNF-L P22S under the Tet-off tetracycline-regulated system (24) . The hNF-L P22S gene was placed under the control of the tet-off promoter to generate the hNF-L P22S transgenic mice (Fig. 1A) . Six Tg (hNF-L P22S ) lines were produced and three of them were kept for their capacity to transmit the transgene: lines 173.2, 173.3 and 176. A DNA construct was then generated with the tTa gene under the control of the Thy1.1 neuron-specific promoter (Fig. 1B) . Three Tg mouse lines were obtained with this construct and analysed for the tTa mRNA expression profile. Line 177 tTa mRNA was expressed specifically in the nervous system with the highest expression in the cerebral cortex and spinal cord (Fig. 1E) . The Tg(tTa) mice were then crossed with the three different Tg (hNF-L P22S ) mouse lines (Fig. 1C) . Genotyping of DNA extracted from mouse tails was determined by Southern blot analysis, therefore discriminating wild-type mice from single and double transgenic mice (Fig. 1D) (Fig. 1F ). This mouse line was used for all further experiments.
Neuronal expression of hNF-L P22S is suppressed by doxycycline treatment
The hNF-L P22S transgene mRNA was amplified by reverse transcriptase -polymerase chain reaction (RT -PCR) with 3 ′ -targeted primers specific for human NF-L sequence. Expression of hNF-L P22S mRNA was detected in the cortex, spinal cord, DRG and at a lower level in cerebellum ( Fig. 2A) . Densitometry analysis of RT -PCR bands for hNF-L mRNA from the spinal cord of hNF-L
P22S
;tTa mice revealed a signal corresponding to 70% of the signal obtained with spinal cord RNA of transgenic mice from mouse line 29 (Supplementary Material, Fig. S1 ) that was reported previously to overexpress normal hNF-L mRNA by two folds the endogenous mouse NF-L levels (25, 26) . So mutant hNF-L P22S mRNA level in the spinal cord of hNF-L ;tTa mice corresponded to half the level of the endogenous mouse NF-L protein. There was no transgene expression in the liver (Fig. 2B ). Both mRNA and protein levels for hNF-L P22S were the highest in the cortex and spinal cord ( Fig. 2A and B) . After 12 week doxycycline treatment, expression of hNF-L P22S mutant was greatly reduced in nervous tissue extracts. Quantification of the signal by optical density revealed that the amount of mutant hNF-L P22S protein was decreased by an average of 77% (Supplementary Material, Fig. S2 ). Immunohistochemical detection of hNF-L with the specific anti-human NF-L antibody DP5-112 revealed a faint staining of cortical and thalamic neurons as well as lumbar motoneurons in hNF-L P22S ;tTa mice (Fig. 2C) . The signal was mainly detected in perikarya compartment compared with axons and dendrites. To identify the cell types expressing mutant hNF-L P22S , double immunofluorescence was carried out with the anti-hNF-L-specific antibody and MAP2 as a neuronal marker or GFAP, a marker for astrocytes (Fig. 2D) . Colocalization of hNF-L with MAP2 was observed in brain sections from hNF-L
;tTa mice (Fig. 2D, upper panel) . No colocalization of hNF-L and GFAP marker could be detected confirming the neuron-specific expression of the hNF-L P22S transgene in hNF-L
;tTa mice (Fig. 2D, lower panel) .
hNF-L P22S ;tTa mice develop aberrant hindlimb posture reminiscent of CMT disease CMT2 is characterized by lower limb motor defects (27) . The hNF-L
;tTa mice recapitulate this feature and start to show abnormal hindlimb posture at 6 months of age (Fig. 3A) . Despite this overt neurological phenotype, the hNF-L
;tTa mice exhibit normal lifespan and body weight. They develop and reproduce normally. Three tests were chosen to analyse and quantify the phenotypes of hNF-L P22S ;tTa mice at 9 months of age. The neurological phenotype was first assessed by the paw-clasping test. The claps duration of hindlimbs with symptomatic hNF-L
;tTa mice was elevated by 5-folds when compared with wt;wt control mice (Fig. 3B ). Mice were then forced to climb a vertical pole. The hNF-L P22S ;tTa mice showed a 35% decrease in the number of segments travelled compared with controls, revealing neuromuscular deficits (Fig. 3C) . Finally, the rotarod test confirmed the loss of sensorimotor functions with a 32% decrease in performance for hNF-L P22S ;tTa mice versus controls (wt;wt) (Fig. 3D) . Thus, the hNF-L P22S ;tTa mice recapitulated the neurological defects that can be associated with CMT. We have to check sensory defects for pain perception using the hot-plate assay. As shown in Supplementary Material, Fig. S3 , the response of hNF-L
;tTa mice did not differ from normal mice. Perhaps, this is not too surprising because the main clinical sign in the CMT disease is distal muscle dysfunction and sensory features are less prominent. It should be noted that we have subjected mice from line 29 (n ¼ 9) overexpressing normal hNF-L by 2-folds to the same paw-clasping and vertical pole climbing tests. The hNF-L overexpressor mice exhibit no overt phenotypes and they performed exactly like nontransgenic mice (wt;wt) in Figure 3 , with average claps duration of 2.6 s and relative distance of 9.5 segments.
Muscle abnormalities and NF-H inclusions in hNF-L P22S
;tTa mice
To further investigate the hindlimb defects detected in hNF-L P22S ;tTa mice, we analysed the morphology of gastrocnemius muscle in hNF-L P22S ;tTa mice. Haematoxylin/eosin staining of transverse sections of lower muscles from hNF-L
P22S
;tTa mice revealed the presence of isolated hypertrophic fibres when compared with muscles from wt;wt control mice (Fig. 4A ). This morphology is reminiscent of CMT2 muscle biopsies that exhibit atrophic fibres as CMT1 as well as hypertrophic fibres (28) . We thus decided to quantify the fibre transectional area by stereology in muscles from both wt;wt and hNF-L P22S ;tTa mice. The distribution of muscle calibres forms a bell-shape curve in both hNF-L P22S ;tTa and wt;wt mice. As expected, the hNF-L
;tTa curve was shifted to the right compared with wt;wt, revealing that the fibre calibre was significantly increased in muscles from hNF-L P22S ;tTa mice when compared with wt;wt littermates (Fig. 4A) . Altered muscle morphology may be associated with motor neuron distress/degeneration. Thus, axons were counted in L5 dorsal and ventral roots from hNF-L
;tTa and wt;wt mice at 9 months of age. No axonal swelling or degeneration was detected in L5 ventral and dorsal roots ( Fig. 4B and C) . However, dissection of both ventral and dorsal roots revealed a specific fragility of the nerves from hNF-L P22S ;tTa mice. Somehow, nerves from hNF-L P22S ;tTa mice had a tendency to break more easily than those from wt;wt mice. This fragility could result from a decreased density of microtubules in axons as described below and consequently a possible lack of resistance to mechanical 
Impaired axonal transport of mitochondria in hNF-L P22S ;tTa neurons
As previous in vitro studies with cultured neuronal cells showed that expression of CMT-linked hNF-L can alter the distribution or the shape of mitochondria (29), we have visualized by time-lapse microscopy the shape and movement of mitochondria in cultured DRG neurons prepared from 13.5-day-old hNF-L P22S ;tTa embryos and wt;wt embryos. Neurons were then treated with Mito-Tracker red to follow axonal transport of mitochondria. The mitochondria in hNF-L
P22S
;tTa neurons exhibited normal shape. However, the duration of individual mitochondria movement as well as excursion length were significantly increased during retrograde transport in hNF-L
;tTa DRG neurons when compared with mitochondria movement in wt;wt neurons ( Fig. 5) . As a consequence, the net anterograde excursion length of mitochondria was diminished in hNF-L P22S ;tTa axons ( Fig. 5C ).
Reversal of phenotypes by administration of doxycycline
The hNF-L P22S ;tTa mice have a neurological and quantifiable phenotype reminiscent of CMT2 pathology. As doxycycline significantly decreases hNF-L P22S expression in the nervous system ( Fig. 2A and B) , we investigated the effects of hNF-L P22S suppression on the phenotypes. Treatment with doxycycline or vehicle (H 2 O) of symptomatic mice and agematched wt;wt mice started at 9 months of age and lasted for a period of 12 weeks. The mouse weight did not differ after treatment with doxycycline compared with non-treated controls ( Fig. 6 ). At 1 day pre-treatment and at 1 day post-treatment, the mice were tested for locomotor performance using the pawclasping test, the vertical pole test and the rotarod test (Fig. 6) . During that period, the phenotypes of hNF-L P22S ;tTa control mice continued to deteriorate, modelling the progressive neuropathy of CMT disease. Remarkably, the 12 week doxycycline treatment rescued most of the motor abnormalities of hNF-L P22S ;tTa mice. When assessed by the paw-clasping test, the hNF-L P22S ;tTa mice treated for 3 months with doxycycline showed a 40% decrease in claps duration when compared with pre-treatment values. This is in sharp contrast to the 55% increase in clasping reflex seen in hNF-L
P22S
;tTa mice treated with vehicle (Fig. 6E) . Doxycycline treatment resulted also in a 49% increase in the number of segments travelled during the vertical wooden beam test, whereas hNF-L
;tTa nontreated mice travelled 55% less than before (Fig. 6F) . Similarly, we observed a 35% amelioration and a 33% deterioration of performance, respectively, for hNF-L
;tTa-treated and non-treated mice during the rotarod test (Fig. 6G) . Analysis of post-treatment motor performance revealed that hNF-L
;tTa mice treated with doxycycline showed a 49% increase in motor performance whereas hNF-L P22S ;tTa mice treated with H 2 O showed a 45% decrease (Fig. 6I) . For the wooden beam and rotarod tests, motor performances of treated hNF-L
;tTa mice were equivalent to wt;wt littermates. The majority (64%) of hNF-L
;tTa mice treated with doxycycline showed more than 25% increase in motor performance between initial and final motor score (Fig. 6J) . In contrast, 73% of hNF-L P22S ;tTa mice treated with H 2 O demonstrated a 25% and greater decrease in motor performance after treatment (Fig. 6J) . Thus, the suppression of hNF-L P22S expression through doxycycline treatment succeeded not only in stopping the progression of the CMT2 phenotypes but also in rescuing most of the motor deficits in this mouse model. Restoration by doxycycline of muscle innervation and of NF distribution along the sciatic nerve
As mentioned above, haematoxylin/eosin staining of transversal muscles sections revealed the presence of hypertrophic fibres reminiscent of CMT2E muscles biopsies in samples from hNF-L
;tTa compared with wt;wt littermates (Fig. 4A) . After 12 weeks of doxycycline treatment, the muscles of hNF-L
;tTa mice exhibited a diminution in the hypertrophic phenotype when compared with hNF-L P22S ;tTa mice treated with H 2 O (Fig. 7A) . Furthermore, we examined whether there was a distal axonal degeneration by measuring the innervation of the gastrocnemius lower muscle. Double immunofluorescence using a-bungarotoxin and SV2/synaptophysin/NF-M antibodies, respectively, as post-and pre-synaptic markers, was performed to assess innervation, semi-innervation and denervation of neuromuscular junctions in wt;wt mice and hNF-L P22S ;tTa mice before and after treatment with either doxycycline or H 2 O (Fig. 7B) . The hNF-L
;tTa mice showed a 30% loss of innervated junctions compared with wt;wt mice before doxycycline treatment (Fig. 7C) . The innervation was restored in these mice upon treatment with doxycycline. The hNF-L
;tTa mice treated with doxycycline showed only 3% denervated junctions when compared with 20% denervated junctions when treated with H 2 O. Basically, after 12 weeks of doxycycline treatment, the innervation of hNF-L P22S ;tTa muscle was equivalent to that of wt;wt littermates (Fig. 7C) , a result consistent with the rescue of motor performance.
The insufficient muscle innervation in hNF-L
;tTa mice prompted us to analyse the distal region of the sciatic nerve. Semi-thin sections of the distal sciatic nerve were prepared from hNF-L P22S ;tTa mice and wt;wt controls treated with doxycycline or H 2 O (Fig. 8C) . No apparent changes in axon morphology were detected in hNF-L P22S ;tTa mice with or without doxycycline treatment when compared with wt;wt littermates (Fig. 8A) . Nevertheless, we further analysed the NF protein content along the sciatic nerve from samples of the nerve cut into five segments from the DRG to the muscle nerve ending. Immunoblotting with an anti-human NF-L antibody DP5-112 confirmed the presence of hNF-L P22S mutant protein along the sciatic nerve of hNF-L
;tTa mice (Fig. 8A) . After treatment of these mice with doxycycline, the level of hNF-L P22S mutant was significantly diminished in the distal segments of the nerve (Fig. 8A) . Immunoblotting was also carried out with antibodies against NF-H, NF-M and NF-L (Fig. 8A) . The western blot signals were analysed by optical density and referred to actin signal to quantify the percentage of each NF subunit along the sciatic nerve. This analysis revealed significant changes in the distribution of NF proteins along the sciatic nerve of hNF-L
;tTa mice when compared with wt;wt littermates (Fig. 8B ). Unlike control samples in which NF proteins were equally distributed along the nerve (20% in each segment), higher levels of NF proteins occurred in the proximal segments (25 -30%) when compared with the distal segments (7 -12%). These changes were more pronounced for the NF-H and NF-M proteins reflecting alterations in stoichiometry of NF proteins along the axon. Treatment of the hNF-L
;tTa mice with doxycycline restored an equal distribution and stoichiometry of NF proteins along the sciatic nerve (Fig. 8B) . Surprisingly, electron microscopy of distal sciatic nerve from hNF-L P22S ;tTa mice revealed a normal NF density neurofilament in axons but a 30% decreased density of microtubules (Fig. 8D) . The reduced density of microtubules was not due to alterations in the levels of a-or b-III tubulins (Fig. 8E) .
DISCUSSION
Here we report, for the first time, the generation and characterization of a transgenic mouse model expressing an hNF-L mutant associated with CMT2E disease. Moreover, this unique animal model was created with the conditional tetracycline-responsive gene system that allows repression of mutant hNF-L P22S transgene expression in adult neurons upon treatment with doxycycline. Expression of hNF-L P22S protein was modest but sufficient to induce an overt neurological phenotype like abnormal hindlimb posture at 6 months of age. Even though the hNF-L
P22S
;tTa mice exhibited a progressive decrease of motor performance during ageing (Fig. 3) , they had a normal lifespan and reproduced normally. This mouse model recapitulates several features of the human CMT2 disease. CMT2 patients suffer from motor deficits mainly in lower limbs without premature death (1) . Histological analysis of gastrocnemius muscle revealed that most of fibres from hNF-L P22S ;tTa mice presented an increased calibre (Fig. 4A) . This muscle hypertrophy in hNF-L
;tTa mice is reminiscent of CMT2 muscle biopsies that show atrophic but also hypertrophic fibres (28). Ericson et al. suggest that muscles in CMT2 become hypertrophic to compensate for the loss of motor units, a consequence of denervation. Accordingly, we observed a 30% loss of lower muscle innervation in hNF-L P22S ;tTa mice (Fig. 7C ). The number of motor axons from the L5 ventral roots of hNF-L P22S ;tTa mice remained unchanged, suggesting that the degeneration process could be more distal. Microscopy examination of distal sections of the sciatic nerve from hNF-L P22S ;tTa mice did not reveal abnormal morphology of axons or signs of degeneration. However, western blot analyses revealed that the presence of hNF-L P22S mutant altered the distribution of NF proteins along the sciatic nerve with an accumulation of NF proteins in the proximal part of the nerve (Fig. 8A) . These changes were more pronounced for the NF-H and NF-M proteins reflecting alterations in stoichiometry of NF proteins along the axon. It is noteworthy that nerve biopsy from CMT patients carrying the P22S NF-L mutation also revealed abnormal NF distribution, but the misaccumulation of NFs seems more pronounced with formation of large axonal swellings and giant axons (16, 19) . Here, it is striking that the normal distribution of NF proteins along the sciatic nerve of hNF-L P22S ;tTa mice was restored upon treatment with doxycycline (Fig. 8A) .
Most NF-L mutants associated with CMT2E are thought to interfere with NF assembly. The over-expression of hNF-L P22S caused disruption of the NF network and massive aggregation of NFs in SW13 2 cells as well as in rat cortical neurons (20) . However, these in vitro results involved high expression levels of mutant NF-L proteins. Here, the hNF-L P22S transgene failed to cause massive aggregation of NFs in spinal motor neurons as expected from the in vitro studies. In hNF-L P22S ;tTa mice, NF-H-positive inclusions were detected in only 5 -10% of lumbar motor neurons. This suggests that the pathogenic effects of hNF-L P22S mutant are mostly unrelated to the NF aggregates. It is remarkable that electron microscopy of distal sciatic nerve from hNF-L
;tTa mice revealed a normal NF density neurofilament in axons but a decreased density of microtubules (Fig. 8D) . These findings are in line with the emerging view of NF protein involvement in the regulation of microtubule dynamics in the axon (30) . Moreover, our time-lapse microscopy studies suggest that the deleterious effects of hNF-L P22S could arise from cytoskeletal alterations that provoke axonal transport defects. Thus, the net anterograde transport of mitochondria was decreased in axons of DRG neurons expressing hNF-L P22S mutant (Fig. 5) . Our results show that expression of hNF-L P22S mutant led to increases in duration and length of retrograde movement of mitochondria. This is consistent with the emerging view of a role for the NF network in controlling the pauses and amplitude of organelle movements in the axon (31) . Similarly, an increase of peripherin concomitant with NFL deficiency provoked a net retrograde transport of mitochondria in DRG neurons (31) . A net retrograde transport could potentially lead to a progressive depletion of axonal mitochondria in distal regions of the nerve with ensuing loss of muscular innervation. A pathogenic mechanism involving mitochondria ;tTa treated with doxycycline(n ¼ 14). Graph represents the percentage of animals that showed increased, stable or decreased performance after treatment. The results are based on a minimum 25% difference between initial and final motor score (x 2 -test, * P , 0.05).
dysfunction is consistent with the report that low levels of NFL P8R and NFL Q333P mutants in cultured motor neurons did not cause large neurofilament aggregates but rather changes in mitochondria morphology (32) . Moreover, CMT2A disease is caused by mutations in mitofusin 2 that provoke mitochondrial rounding due to impaired fusion and reduction in axonal mitochondria transport (33) .
CMT is the most common inherited peripheral neuropathy with an incidence of 1 in 2500. No pharmacological treatment is currently available and the genetic heterogeneity complicates the development of new treatments. The use of the tet-off system gave us the opportunity to address whether the CMT type 2E disease is potentially reversible. Upon suppression of hNF-L P22S expression by doxycycline treatment, the phenotype of hNF-L
;tTa mice was almost completely abolished with a 64% improvement in motor performance (Fig. 6E -G) . Moreover, the improved performance was accompanied by reinnervation of neuromuscular junctions in gastrocnemius and diminution of muscle hypertrophy. Muscular denervation is a pathological event in both CMT1 and CMT2. However, in CMT2, the neuromuscular junctions remain denervated whereas CMT1 muscle alternates between innervation and denervation. Our results show that abolishing hNF-L P22S expression promotes muscle reinnervation in a CMT2E transgenic mouse model, demonstrating that the neurological deficits detected in hNF-L P22S ;tTa mice require the continuous production of mutant hNF-L P22S protein and are potentially reversible.
The hNF-L P22S ;tTa double transgenic mice described here mimic many aspects of the human CMT2E disease, including motor disability, abnormal muscle morphology and denervation events. Our data highlight the importance of the integrity of the NF network for neuronal function and suggest that the disease symptoms caused by the NEFL P22S mutation might result from axonal transport defects rather than deleterious effects of large NF aggregates. The hNF-L
;tTa mice should provide a useful tool for testing experimental therapeutics. In future, a variety of approaches that target hNF-L mutants might be considered, including the use of antisense oligonucleotides and RNA interference aiming to reduce ;tTa mice treated with doxycycline. Neurofilaments were present equally along the sciatic nerve in wt;wt mice and hNF-L P22S ;tTa mice with doxycycline, but their levels were significantly higher in proximal segments in hNF-L P22S ;tTa mice with H 2 O. n ¼ 4, unpaired t-test, * P , 0.05; * * P , 0.01. (D) Electron microscopy revealed a normal neurofilament density but a decreased density of microtubules in distal sciatic nerve from hNF-L P22S ;tTa mice. Arrowheads point toward MT, whereas the asterisk indicates NF. Bar, 0.1 mm. Error bars indicate SEM. * * * P , 0.0001.
expression of hNF-L mutant, inducers of heath shock proteins (32) or phosphorylation of the hNF-L head domain by protein kinase A (20) aiming to alleviate misfolding of hNF-L mutant proteins. Our findings provide hope that future therapeutic strategies might not only stop progress of CMT2E disease but also reverse the disabilities.
MATERIALS AND METHODS
Generation of the hNF-L P22S ;tTa mice
To generate the hNF-L P22S transgenic mice, we digested a vector containing the hNF-L P22S mutated gene. The obtained 4.5 kb XbaI DNA fragment were then subcloned into the XbaI sites of the pUHD10.3 vector upstream from the SV40 polyadenylation site. pUHD10.3 contains the tet-responsive element (TRE), consisting of a minimal human cytomegalovirus promoter fused to seven copies of the 19 bp inverted repeat tetracycline operator (tetO) sequences (34) . The modified pUHD10.3-hNF-L vector was then digested by EcoRV and SapI. The 5.7 kb targeted fragment contained the inducible TRE, the hNF-L P22S mutated gene and the SV40 polyadenylation site (Fig. 1A) . It was microinjected into fertilized C57BL6 × C3H (B6C3/F1) mouse eggs and then implanted into pseudopregnant females. Potential founders and Tg(hNF-L) offspring were identified by Southern blotting as described previously (25), using a 0.9 kb BglII fragment of the hNF-L gene as a probe on BamHI digested genomic DNA from mouse tails (Fig. 1C) . A 5 kb NotI/XhoI fragment containing the human Thy1tTa neuron-specific promoter, tTa gene and the SV40 polyadenylation signal was microinjected as described earlier (pSK-hThy1tTa vector, Fig. 1B) . A EcoRI/BamHI fragment of the pTet-Off vector (BD Biosciences Clontech, Missisauga, ON, Canada) was used as a probe to genotype the different founders and the latter offspring. This probe detected a 1.3 kb band from BamHI-digested genomic DNA obtained from tail samples (Fig. 1D) .The hNF-L P22S transgenic mice were crossed with the tTa mice to obtain the double transgenic mice hNF-L
P22S
;tTa (Fig. 1C) . Double transgenic mice and littermate wt;wt controls were daily treated with doxycycline or H 2 O during 12 weeks. The treatment consists in a mixture of doxycycline/sucrose 1:25 diluted in H 2 O for the mice to drink.
The use of animals and all surgical procedures described in this article were carried out according to The Guide to the Care and Use of Experimental Animals of the Canadian Council on Animal Care.
Reverse transcriptase -polymerase chain reaction
Total RNA from the cortex, cerebellum, spinal cord and DRG was extracted with trizol reagent according to the manufacturing instructions (Invitrogen, Burlington, ON, USA). Firststrand cDNA synthesis was performed using Superscript III reverse transcriptase (Invitrogen) according to the manufacturer's protocol. PCR was performed with Taq platinum DNA polymerase (Invitrogen) with the following primers: 5 ′ -ATAACCAGTGGCTACTCCCAGA-3 ′ and 5 ′ -ATCCTG AACTCATAAGCGTGGT-3 ′ for specific human NEFL cDNA amplification. RT-PCR products were separated by electrophoresis on agarose gel.
Western blot
After dissection, tissues were first gently homogenized in Tris -Triton buffer [10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 2 mM phenylmethylsulfonyl fluoride (PMSF), 1% Triton X-100]. After centrifugation at 10 000g for 15 min at 48C, the insoluble fraction was then homogenized in a SUB denaturing buffer (0.5% SDS/8 M urea in 7.4 phosphate buffer) with a pool of protease inhibitors [PMSF, protease inhibitor cocktail (Sigma, Saint-Louis, MI, USA)].
Homogenates were centrifuged at 10 000g for 20 min at room temperature (RT). The protein concentration of the supernatant was determined by the method of Bradford. Equal amounts of protein were loaded on SDS-PAGE and transferred to a methanol activated PVDF membrane (Perkin and Elmer, Waltham, MA, USA). The membrane was blocked with 1× phosphate-buffered saline (PBS); 0.1% Triton; 2% horse serum; 2% bovine serum albumin (BSA). They were then incubated with a 1:500 dilution of specific hNF-L70 antibody (MAB 5294, Chemicon, Temecula, CA, USA) in blocking buffer overnight at RT. The other antibodies used were NF-H (N52), NF-M (NN18), actin (Chemicon) and NF-L NR4 (Sigma). Incubation with the secondary antibody diluted 1:2500 in blocking buffer (Jackson Immunoresearch, West Grove, PA, USA) was done at RT for 30 min. Detection was by chemiluminescence (Perkin and Elmer, Waltham, MA, USA).
Immunohistochemistry
Mice were perfused with 0.9% NaCl and fixed with 4% paraformaldehyde (PFA), pH 7.4. Spinal cord were dissected, postfixed overnight and then placed in 10% sucrose PBS. Brains and spinal cords were sectioned on a microtome in 25 mm sections. Tissues were stored at 2208C in a cryopreservative solution and used for immunodetection. The rinsed tissues were mounted on superfrost slides (Fisher, Ottawa, ON, USA). They were washed in PBS and incubated in PBS -sodium borohydride for 30 min at RT for antigenic demasking. The slices were incubated in 0.6% H 2 O 2 solution for 15 min at RT to block endogenous peroxidase. After washing, the samples were preincubated for 1 h at RT in blocking solution (PBS containing 0.25% Triton X-100, 5% goat serum). The slices were incubated overnight at RT with the appropriate dilution of primary antibody [N52 (NF-H), NN18 (NF-M), DP5-112 (hNF-L70), Chemicon, except Sigma for NR4 (NF-L)] in PBS; 0.25% Triton X-100; 1% goat serum. The slices were then washed and incubated for 90 min at RT in the secondary biotinylated Ab solution 1/500 in potassium PBS containing 0.25% Triton X-100; 1% goat serum. After washing, the sections were incubated in ABC complex for 1 h at RT. Staining was developed by incubating the samples in DAB solution (Vector kit). Tissues were counterstained with haematoxylin, dehydrated in graded concentrations of EtOH and xylene and coverslipped with DPX.
Immunofluorescence
After incubation with primary Ab (hNF-L70, MAP2, GFAP, Chemicon), the tissue sections were washed in PBS -0.25% Human Molecular Genetics, 2010Triton X-100 and then incubated for 90 min in secondary Ab (Alexa Fluor w , Invitrogen) diluted 1:500 in potassium PBS containing 0.25% Triton X-100; 1% goat serum. The sections were finally coverslipped with fluoromount (Electron Microscopy Science, Hatfield, PA, USA).
For monitoring the neuromuscular junctions, 25 mm thick muscle sections were incubated for 1 h in 0.1 M glycine in PBS for 2 h at RT and then stained with Alexa Fluor w 594-conjugated a-bungarotoxin (1:2000, Molecular Probes/ Invitrogen detection technologies, Carlsbad, CA, USA) diluted in 3% BSA in PBS for 3 h at RT. After washing in PBS, the muscle sections were blocked in 3% BSA, 10% goat serum and 0.5% Triton X-100 in PBS overnight at 48C. The next day, the sections were incubated with mouse antineurofilament antibody 160 K (1:2000, Temecula, CA, USA), mouse synaptic vesicle antibody SV2 (1:30, Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA, USA) and mouse anti-synaptophysin (Dako, Mississauga, ON, Canada) in the same blocking solution overnight at 48C. After washing for 5 h with 1% Triton X-100 in PBS, muscle sections were incubated with goat anti-mouse Alexa Fluorw 488-conjugated secondary antibody (Probes/Invitrogen detection technologies, Carlsbad, CA, USA) diluted 1:500 in blocking buffer for 3 h at RT. Muscle sections were washed in PBS and finally coverslipped with fluoromount (Electron Microscopy Science). Total and partial colocalization of a-bungarotoxin with SV2/synaptophysin/NF-M markers characterizes the muscular innervation state; partial colocalization corresponds to semi-innervated junctions whereas a-bungarotoxin staining alone represents denervation. Three hundred neuromuscular junctions were counted per animal sample, discriminating both innervated and denervated junctions as described above. Frequencies of innervation, semi-innervation and denervation were then converted to percentages for statistical analyses (n ¼ 5, two-way ANOVA with Bonferroni post-test).
Axon count
Dorsal root ganglia from 9-month-old mice were dissected after perfusion with PFA and then post-fixed in 3% glutaraldehyde (n ¼ 3). Tissue samples were washed three times in 0.1 M NaHPO 4 , pH 7.4, and then treated with 2% osmium tetroxide in 0.1 M NaHPO 4 for 2 h at 208C, followed by dehydration in increasing concentrations of EtOH and in acetone. The final dehydratation was for 1 h at RT with 50% epoxy resin in acetone. Ventral (VR) and dorsal roots (DR) were properly separated and embedded in epoxy resin for at least 2 h at RT before heating overnight at 608C. Resulting blocks were sliced in 1 mm semi-thin sections and stained with toluidine blue. Axons were counted with the MetaMorph Imaging System (Universal Imaging Corp., Downingtown, PA, USA).
Locomotor tests
Mice were tested 1 day before doxycycline treatment and 1 day post-treatment for the three tests. The paw-clasping phenotype consists of recording the total amount of time that the mice spend clasping their hindlimbs when suspended by the tail (unpaired, paired t-test, * P , 0.05). The vertical pole test assesses the potential neuromuscular defects in mice. Animals were allowed to climb the pole and the number of segments travelled was compared according to genotypes (unpaired, paired t-test, * P , 0.05). Finally, mice were submitted to the rotarod test with the following parameters: starting rpm ¼ 0, acceleration 0.2 rpm/s. The best score in four assays was recorded and compared according to the genotype (unpaired, paired t-test, * P , 0.05).
Primary culture of DRG neurons DRG cultures were prepared from E13.5 embryos as described previously (35) . The detection of both Thy1-tTa and tetO-hNF-L P22S transgenes in doubly transgenic embryos used to prepare primary cultures of DRG neurons was done as described in Supplementary Material, Figure S4 . Briefly, DRG were dissected and dissociated for 15 min at 378C in 0.05% trypsin, 0.53 mM EDTA (Invitrogen). After trypsinization, DRG were rinsed with L-15-containing trypsin inhibitor (1 mg/ml) (Sigma) and were then triturated. Neurons were plated onto four-well plates (LabTek, Rochester, NY, USA) precoated with poly-D-lysine and extracellular matrix (Sigma) and maintained in Neurobasal medium supplemented with B-27 supplement, glutamine (0.5 mM), nerve growth factor (15 ng/ml) and penicillin/streptomycin (all from Invitrogen). In order to determine the orientation of the axons in the timelapse movies, the neurons are cultured at low density, so that axons can be traced from the cell body to the growth cone.
Microscopy
Neuronal mitochondria were labelled for 1 min at 378C with 50 nM chloromethyl-X-rosamine (MitoTracker Red CMXRos). Neurons were washed and then replaced in complemented medium without phenol red. Observations occurred at least 1 h after the washout of MitoTracker. Time-lapse recordings of mitochondrial movement were acquired every 5 s for 10 min with a Nikon TE2000 inverted microscope equipped with a Hamamatsu 1394 Orca-ER CCD digital camera (Hamamatsu Photonics, Welwyn Garden City, UK), TRITC filter set, and ×40 HMC CFI Plan Fluor ELWD objective (Nikon). The cells were maintained at 378C in a sealed observation chamber (Solent Scientific, Segensworth, UK) during image acquisition. We used short exposure times (150 ms) and neutral density filters to minimize photobleaching and phototoxicity. Collection of image stacks was made using the MetaMorph Imaging System (Universal Imaging Corp.).
Image analysis
Data were collected from 15-30 neurons from at least three different primary cultures maintained for 2 -3 days in vitro.
To avoid measuring movements due to axonal retraction, only axons that did not move relative to the substratum during the observation were analysed. Unlike other studies, we did not use a kymograph to measure the kinetic properties of organelle transport because this method does not allow identifying short-term movements as well as frequent changes in direction. We thus performed a manual analysis of mitochondrial movements. The percentage of moving mitochondria was determined in each time-lapse movie. The instantaneous rate of transport was determined by dividing the distance covered by a carrier without stopping or reversing direction by the elapsed time. The frequency of reversal was calculated by dividing the number of changes in direction by the time in motion. Percentages of anterograde and retrograde movements, number of movements per minute and duration of pauses were also measured. Finally, the net length was determined by measuring the distance between the initial and the final tracking points of individual mitochondria. Statistical analyses were performed using GraphPad InStat, version 3.05 (GraphPad Software, San Diego, CA, USA). The percentage of moving mitochondria was compared by one-way ANOVA followed by the Newman -Keuls multiple comparison test. Frequencies of anterograde and retrograde movements and frequencies of slow and fast movements were compared by Yates corrected x 2 test. Size of organelles, transport activity, duration and length of individual movements, net excursion length, duration of pauses, number of changes in direction and mean rates of transport were tested by using a Kruskal -Wallis non-parametric test followed by Dunn's multiple comparison test. P-values of ,0.05 were considered significant.
